Business Context and Reporting Period
This Form 8-K is a current report filed by Supernus Pharmaceuticals, Inc. on July 29, 2014. The filing serves to announce the scheduled release of financial results for the quarter ended June 30, 2014.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding the timing of the upcoming earnings release rather than a financial statement.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely communicates the schedule for the upcoming second-quarter 2014 results.
Guidance, Outlook, and Management Commentary
- Earnings Release Date: The company expects to report financial results for the quarter ending June 30, 2014, after 5:00 PM ET on August 11, 2014.
- Conference Call: A conference call and webcast to review the second-quarter 2014 financial results are scheduled for August 12, 2014.
- Exhibits: A press release dated July 29, 2014, is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the actual financial results released on or after August 11, 2014, as this filing contains no performance data.
- Confirm the details of the conference call scheduled for August 12, 2014, for management commentary.
- Review the full text of the press release (Exhibit 99.1) for any additional context not summarized in the 8-K body.